Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma

被引:2
|
作者
Lukesova, S. [2 ,6 ]
Kopecky, O. [1 ,2 ,6 ]
Vroblova, V. [3 ]
Hlavkova, D. [3 ]
Andrys, C. [3 ]
Moravek, P. [4 ]
Cermakova, E. [5 ]
机构
[1] Charles Univ Prague, Fac Med, Hradec Kralove 50005, Czech Republic
[2] Univ Teaching Hosp, Dept Internal Med 2, Hradec Kralove 50005, Czech Republic
[3] Univ Teaching Hosp, Inst Clin Immunol & Allergol, Hradec Kralove 50005, Czech Republic
[4] Univ Teaching Hosp, Dept Urol, Hradec Kralove 50005, Czech Republic
[5] Univ Teaching Hosp, Comp Technol Ctr, Hradec Kralove 50005, Czech Republic
[6] Dist Hosp Ndchod, Dept Oncol, Nachod, Czech Republic
关键词
renal cell carcinoma; angiogenin; PDGF; MCP-1; protein array method;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using the protein array method we determined the serum levels of a number of angiogenic factors. We identified serum levels of angiogenin, PDGF and MCP-1 (CCL2 chemokine) in serum of 32 patients with RCC, and 14 healthy volunteers by means of antibody array analysis. The patients were divided into three groups according to their disease stages (I+II, III, and IV). We found significant differences between the controls and patients with RCC both pre-operatively and post-operatively in angiogenin, PDGF and MCP-1 serum levels. The increase in angiogenin, PDGF and MCP-1 lasted in patients with RCC stages I-III even without metastases eight weeks post-operatively. The patients with stage IV RCC showed disturbed production of PDGF and MCP-1. Protein array analysis is a powerful tool for the identification of large numbers of trace proteins. Multiplex antibody array is able to provide data more precisely reflecting the nature of pathological processes.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [41] Plasma cytokines and angiogenic factors (CAFs) for evaluation of risk of recurrence and classification of patients (pts) with nonmetastatic renal cell carcinoma (RCC).
    Khajavi, Mehrdad
    Jonasch, Eric
    Wang, Xuemei
    Wood, Christopher G.
    Matin, Surena F.
    Fiorentino, Stefania
    McKee, Kathryn S.
    Tran, Hai T.
    Heymach, John
    Zurita, Amado J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome
    Raevens, Sarah
    Coulon, Stephanie
    Van Steenkiste, Christophe
    Colman, Roos
    Verhelst, Xavier
    Van Vlierberghe, Hans
    Geerts, Anja
    Perkmann, Thomas
    Horvatits, Thomas
    Fuhrmann, Valentin
    Colle, Isabelle
    LIVER INTERNATIONAL, 2015, 35 (05) : 1499 - 1507
  • [43] Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma
    Edeline, Julien
    Mottier, Stephanie
    Vigneau, Cecile
    Jouan, Florence
    Perrin, Christophe
    Zerrouki, Selim
    Fergelot, Patricia
    Patard, Jean-Jacques
    Rioux-Leclercq, Nathalie
    HUMAN PATHOLOGY, 2012, 43 (11) : 1982 - 1990
  • [44] Evaluation of serum and urinary angiogenic factors in patients with endometriosis
    Cho, Si Hyun
    Oh, Yoon Jin
    Nam, Anna
    Kim, Hye Yeon
    Park, Joo Hyun
    Kim, Jae Hoon
    Park, Ki Hyun
    Cho, Dong Je
    Lee, Byung Seok
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 58 (06) : 497 - 504
  • [45] Role of angiogenic factors in serum of patients with hepatopulmonary syndrome
    Raevens, Sarah
    Coulon, Stephanie
    Van Steenkiste, Christophe
    Colman, Roos
    Van Vlierberghe, Hans
    Geerts, Anja M.
    Perkmann, Thomas
    Horvatits, Thomas
    Fuhrmann, Valentin
    Colle, Isabelle
    HEPATOLOGY, 2013, 58 : 982A - 983A
  • [46] Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma
    Klatte, Tobias
    Boehm, Malte
    Nelius, Thomas
    Filleur, Stephanie
    Reiher, Frank
    Allhoff, Ernst Peter
    BJU INTERNATIONAL, 2007, 100 (01) : 209 - 214
  • [47] Prognostic factors for survival of patients with metastatic renal cell carcinoma
    Ohlmann, C. -H.
    UROLOGE, 2009, 48 (06): : 625 - 626
  • [48] Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma
    Mian, BM
    Bhadkamkar, N
    Slaton, JW
    Pisters, PWT
    Daliani, D
    Swanson, DA
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (01): : 65 - 70
  • [49] Prognostic Factors in Patients with Renal Cell Carcinoma and Brain Metastases
    Sperduto, P. W.
    Deegan, B. J.
    Li, J.
    Jethwa, K. R.
    Brown, P. D.
    Lockney, N. A.
    Beal, K.
    Rana, N. G.
    Attia, A.
    Shanley, R.
    Lou, E.
    Zahra, A.
    Buatti, J.
    Molitoris, J. K., Jr.
    Yu, J. B.
    Chiang, V. L.
    Masucci, G. L.
    Roberge, D.
    Olson, A. C.
    Kirkpatrick, J. P.
    Braunstein, S. E.
    Sneed, P. K.
    Shi, D. D.
    Shih, H. A.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S169 - S170
  • [50] Prognostic factors in patients with advanced renal cell carcinoma.
    Pardo, P.
    Muriel, C.
    Esteban, E.
    Izquierdo, M.
    Astudillo, A.
    Martinez-Camblor, P.
    Corral, N.
    Crespo, G.
    Berros, J. P.
    Lacave, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)